Clinical tissue samples indicated that WNT3A expression was significantly higher in BC tissues than in adjacent normal tissues and was even higher in the tumour tissues of patients with lymph node metastasis than in those without (Figure 5G,H). This evidence concerns the gene WNT3A and breast cancer.